Insiders / Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV General Partner LLC
CIK 1508051institutionfundinsiderbeneficial owner
Companies
4
First seen
Feb 4, 2021
Last activity
Aug 14, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Axcella Health Inc. · AXLA | 29,251,545 | — |
| Evelo Biosciences, Inc. · EVLO | 11,530,801 | — |
| Rubius Therapeutics, Inc. · RUBY | 5,789,414 | — |
| Kaleido Biosciences, Inc. · KLDO | 1,649,999 | — |
All securities held
4 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Axcella Health Inc. | Common stock | 29,251,545 |
| Evelo Biosciences, Inc. | Common stock | 11,530,801 |
| Kaleido Biosciences, Inc. | Common stock | 1,649,999 |
| Rubius Therapeutics, Inc. | Common stock | 5,789,414 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| May 27, 2022 | Buy Open-market buy | EVLO Evelo Biosciences, Inc. Common Stock | $20.00M | +13.7M | 13,698,630 | high |
| May 27, 2022 | Buy Open-market buy | EVLO Evelo Biosciences, Inc. Common Stock | $10.00M | +6.8M +499.78% | 8,219,791 | high |
| Jul 11, 2023 | Buy Open-market buy | EVLO Evelo Biosciences, Inc. Common Stock | $7.50M | +3.2M +474.03% |